Studies on the rabies vaccine On the development of rabicidal antibodies in dogs and cows, immunized with Merzonin-vaccine and other live anti-rabies vaccines for canine use
Otani, S.
Yokohama Med Bull: 121-129
1950
Accession: 025589550
Merzonin vaccine was prepd. from a 10% emulsion in normal saline soln. of rabbit brain infected with fixed rabies virus. Virus was inactivated by exposure to 0.1% Merzonin and 37 temp. for 5 days.
PDF emailed within 1 workday: $29.90
Related References
Yaoi, H.; Takei, M.; Maeda, H.; Yaoi, H. 1953: Studies on the rabies vaccine. Xth report: Resistance to rabies and rabicidal antibodies in dogs, immunized with inactivated anti-rabies vaccine Yokahama Med Bull 4(3): 129-141Yaoi, H.; Takei, M.; Maeda, H.; Yaoi, H. 1953: Studies on the rabies vaccine. X. Resistance to rabies and rabicidal antibodies in dogs, immunized with inactivated anti-rabies vaccine Yokohama Medical Bulletin 4(3): 129-141
Oshima, Y. 1959: Studies on inactivated rabies vaccine of chick embryo origin. III. Some experiments concerning practical application on inactivated merzonin-cystine anti-rabies vaccine Japanese Jour Vet Sci 21(4): 207-214
OSHIMA.Yasuo 1959: Studies on inactivated rabies vaccine of chick embryo origin II A method of preparation of inactivated merzonin-cystine anti-rabies vaccine The Japanese Journal of Veterinary Science 21(4): 199-205
Yaoi, H.; Takei, M.; Maeda, H. 1952: Studies on the rabies vaccine. VIII. Prophylactic immunization of dogs by means of merzonin-inactivated antirabies vaccine Yokohama Medical Bulletin 3(3): 140-150
Takayama, N.; Suganuma, A.; Kasai, D.; Kurai, D. 2002: Anti-rabies antibody titers among subjects who received rabies post-exposure prophylaxis with foreign-made rabies vaccines at the beginning and followed with Japanese rabies vaccine Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 76(10): 882-887
Yaoi, H.; Nakagami, S.; Nakano, M.; Kondo, A. 1949: Studies on rabies vaccine. I. Inactivation of fixed rabies virus with merzonin and heat Japanese Jour Exptl Med 20(3): 393-399
Yaoi, H.; Takei, M.; Maeda, H.; Saito, K.; Yamasawa, R. 1953: Studies on the rabies vaccine . IX. Investigation into materials for making Merzonin vaccine Yokohama Med Bull 3(4): 118-189
Yaoi, H.; Takei, M.; Maeda, H.; Saito, K.; Yamasawa, R. 1952: Studies on the rabies vaccine. IX. Investigation into materials for making merzonin vaccine Yokohama Medical Bulletin 3(4): 181-189
Maeda, H. 1955: Studies on the rabies vaccine XIIIth report On the glycerinated merzonin vaccine Yokohama Med Bull: 359-374
Yaoi, H.; Maeda, H. 1955: Studies on the rabies vaccine. XIII. on the glycerinated merzonin vaccine Yokohama Medical Bulletin 6(6): 359-374
Yaoi, H.; Gotto, N.; Yamasawa, R.; Nagata, A. 1956: Studies on the rabies vaccine. XIVth report: On the effects of PVL and cortisone upon immunizing power of anti -rabies vaccine Yokohama Med Bull 7(6): 371-382
Berlin, B.S.; Mitchell, J.R.; Burgoyne, G.H.; Brown, W.E.; Goswick, C. 1983: Rhesus diploid rabies vaccine (adsorbed), a new rabies vaccine. II. Results of clinical studies simulating prophylactic therapy for rabies exposure JAMA 249(19): 2663-2665
Yaoi, H.; Mikamo, Y.; Otani, S.; Nakagami, S.; Nakano, M.; Kondo, A. 1950: On a new anti-rabies vaccine, inactivated completely by Merzonin and heat Yokohama Med Bull 1(1): 15-25
Pfaff, F.; Müller, T.; Freuling, C.M.; Fehlner-Gardiner, C.; Nadin-Davis, S.; Robardet, E.; Cliquet, F.; Vuta, V.; Hostnik, P.; Mettenleiter, T.C.; Beer, M.; Höper, D. 2019: In-depth genome analyses of viruses from vaccine-derived rabies cases and corresponding live-attenuated oral rabies vaccines Vaccine 37(33): 4758-4765
Yaoi, H.; Goto, N.; Yamasawa, R.; Nagata, A. 1956: Studies on the rabies vaccine. XIV. on the effects of PVL and cortisone upon immunizing power of anti-rabies vaccine Yokohama Medical Bulletin 7(6): 371-382
Yaoi, H.; Takei, M.; Kimura, Y. 1953: Studies on the rabies vaccine. XI. on the toxicity of merzonin Yokohama Medical Bulletin 4(3): 142-145
Yaoi, H.; Takei, M.; Maeda, H.; Yaoi, H. 1953: Studies on the rabies vaccine. XIIth Report: Further studies on the method of preparation and storage of the inactivated anti- rabies vaccine Yokohama Med Bull 4(4): 185-198
Yaoi, H.; Takei, M.; Kiumura, Y. 1953: Studies on the rabies vaccine, XIth report: On the toxicity of merzonin Yokohama Med Bull 4(3): 142-145
Lakshmanan, N.; Gore, T.C.; Duncan, K.L.; Coyne, M.J.; Lum, M.A.; Sterner, F.J. 2006: Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus Veterinary Therapeutics: Research in Applied Veterinary Medicine 7(3): 223-231